Rituximab As an Effective and Probably Safe Treatment for Granulomatosis With Polyangiitis (Wegener's Granulomatosis)

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):

Share By

Rituximab As an Effective and Probably Safe Treatment for Granulomatosis With Polyangiitis (Wegener's Granulomatosis) Publisher Pubmed

Tavakolpour S^{1, 2} ; Alesaeidi S²

Source: International Immunopharmacology Published:2019

Abstract

[No abstract available]

Related Docs

View other Related Docs

1. The Efficacy and Safety of Rituximab in Anca-Associated Vasculitis: A Systematic Review, Biology (2022)

2. Current Understanding and Unknown Aspects of the Treatment of Granulomatosis With Polyangiitis (Wegener’S Granulomatosis): Opportunities for Future Studies, Current Rheumatology Reviews (2020)

3. Two Decades Rituximab Therapy in Anti-Neutrophil Cytoplasmic Antibody Associated Vasculitis, Current Drug Targets (2025)

Experts (# of related papers)

View all Related Experts

Sasan Dabiri Satri (1)

Arash Jafarieh (1)

Other Related Docs

4. Successful Treatment Strategies in Granulomatosis With Polyangiitis-Associated Peripheral Ulcerative Keratitis, Cornea (2016)

Style	Citing Format
MLA	Tavakolpour S, Alesaeidi S. "Rituximab As an Effective and Probably Safe Treatment for Granulomatosis With Polyangiitis (Wegener's Granulomatosis)." International Immunopharmacology, vol. 70, no. , 2019, pp. 67-68.
APA	Tavakolpour S, Alesaeidi S (2019). Rituximab As an Effective and Probably Safe Treatment for Granulomatosis With Polyangiitis (Wegener's Granulomatosis). International Immunopharmacology, 70(), 67-68.
Chicago	Tavakolpour S, Alesaeidi S. "Rituximab As an Effective and Probably Safe Treatment for Granulomatosis With Polyangiitis (Wegener's Granulomatosis)." International Immunopharmacology 70, no. (2019): 67-68.
Harvard	Tavakolpour S, Alesaeidi S (2019) 'Rituximab As an Effective and Probably Safe Treatment for Granulomatosis With Polyangiitis (Wegener's Granulomatosis)', International Immunopharmacology, 70(), pp. 67-68.
Vancouver	Tavakolpour S, Alesaeidi S. Rituximab As an Effective and Probably Safe Treatment for Granulomatosis With Polyangiitis (Wegener's Granulomatosis). International Immunopharmacology. 2019;70():67-68.
BibTex	@article{ author = {Tavakolpour S and Alesaeidi S}, title = {Rituximab As an Effective and Probably Safe Treatment for Granulomatosis With Polyangiitis (Wegener's Granulomatosis)}, journal = {International Immunopharmacology}, volume = {70}, number = {}, pages = {67-68}, year = {2019} }
RIS	TY - JOUR AU - Tavakolpour S AU - Alesaeidi S TI - Rituximab As an Effective and Probably Safe Treatment for Granulomatosis With Polyangiitis (Wegener's Granulomatosis) JO - International Immunopharmacology VL - 70 IS - SP - 67 EP - 68 PY - 2019 ER -

Science Communicator Platform

Authors

Abstract